An N-nitrosating metalloenzyme constructs the pharmacophore of streptozotocin
Access StatusFull text of the requested work is not available in DASH at this time ("dark deposit"). For more information on dark deposits, see our FAQ.
Ng, Tai L.
Mitchell, Andrew J.
Boal, Amie K.
Balskus, Emily P.
MetadataShow full item record
CitationNg, T.L., Rohac, R., Mitchell, A.J. et al. An N-nitrosating metalloenzyme constructs the pharmacophore of streptozotocin. Nature 566, 94–99 (2019). https://doi.org/10.1038/s41586-019-0894-z
AbstractN-nitroso-containing small molecules, such as the bacterial natural product streptozotocin, are prominent carcinogens as well as important cancer chemotherapeutics. Despite this functional group’s significant impact on human health, dedicated enzymes involved in N-nitroso assembly have not been identified. Here, we describe a metalloenzyme from streptozotocin biosynthesis (SznF) that catalyzes an unprecedented oxidative rearrangement of the guanidine group of Nw-methyl-L-arginine to generate an N-nitrosourea product. Structural characterization and mutagenesis of SznF uncovered two separate active sites that promote distinct steps in this transformation using different iron-containing metallocofactors. The discovery of this biosynthetic reaction, which has little precedent in enzymology or organic synthesis, expands the catalytic capabilities of non-heme iron-dependent enzymes to include N–N bond formation. We find biosynthetic gene clusters encoding SznF homologs are widely distributed among bacteria, including environmental organisms, plant symbionts, and human pathogens, suggesting an unexpectedly diverse and uncharacterized microbial reservoir of bioactive N-nitroso metabolites.
Citable link to this pagehttps://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37366569
- FAS Scholarly Articles